The role of atypical pathogens in community-acquired pneumonia

Seminars in Respiratory and Critical Care Medicine

Volumn 33, Issue 3, 2012, Pages 244-256

  Marrie, Thomas J ^a   Costain, Nicholas ^a   La Scola, Bernard ^b,c   Patrick, Ward ^a   Forgie, Sarah ^d,e   Xu, Zhaolin ^f,g   McNeil, Shelly A ^f  

^a DALHOUSIE UNIVERSITY   (Canada)

^b AIX MARSEILLE UNIVERSITY   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^d UNIVERSITY OF ALBERTA   (Canada)

^e Canada Edmonton Clinic Health Academy (ECHA)   (Canada)

^f DALHOUSIE UNIVERSITY   (Canada)

^g QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

atypical; community acquired; pneumonia; viral

Indexed keywords

PROCALCITONIN;

2009 H1N1 INFLUENZA; ADENOVIRUS; BACTERIAL PNEUMONIA; BOCAVIRUS; CHLAMYDOPHILA PNEUMONIAE; CHLAMYDOPHILA PSITTACI; COMMUNITY ACQUIRED PNEUMONIA; CORONAVIRUS; COXIELLA BURNETII; CYTOMEGALOVIRUS; EMERGENCY WARD; ENTEROVIRUS; EPSTEIN BARR VIRUS; HANTAVIRUS; HERPES SIMPLEX VIRUS; HOSPITALIZATION; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; HUMAN METAPNEUMOVIRUS; LEGIONELLA; LEGIONELLA PNEUMOPHILA; LEGIONNAIRE DISEASE; MEASLES VIRUS; MIMIVIRUS; MULTIPLEX POLYMERASE CHAIN REACTION; MYCOPLASMA PNEUMONIAE; PARAINFLUENZA VIRUS; POLYOMA VIRUS; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; RHINOVIRUS; SENSITIVITY ANALYSIS; VARICELLA ZOSTER VIRUS; VIRUS PNEUMONIA; YERSINIA PESTIS;

ADENOVIRUS INFECTIONS, HUMAN; CHLAMYDIAL PNEUMONIA; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; INFLUENZA, HUMAN; LEGIONELLOSIS; LEGIONNAIRES' DISEASE; MULTIPLEX POLYMERASE CHAIN REACTION; PNEUMONIA, BACTERIAL; PNEUMONIA, VIRAL; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

EID: 84862491013     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0032-1315636     Document Type: Review

References (147)

1. Reimann HA. An acute infection of the respiratory tract with atypical pneumonia. JAMA: 1938; 111 2377 2384
2. Marrie TJ, Haldane EV, Noble MA, Faulkner RS, Martin RS, Lee SHS. Etiology of atypical pneumonias - a one year prospective study. CMAJ: 1981; 125 1118 1123 (Pubitemid 12244479)
3. Arnold FW, Summersgill JT, Lajoie AS., et al. Community-Acquired Pneumonia Organization (CAPO) Investigators A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med: 2007; 175 10 1086 1093 (Pubitemid 46741761)
4. Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman AW, van den Broek PJ, Claas EC. Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis: 2005; 41 3 345 351 (Pubitemid 41022112)
5. Kuiken T, Fouchier RAM, Schutten M., et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet: 2003; 362 9380 263 270 (Pubitemid 36936836)
6. Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia. Lancet: 2011; 377 9773 1264 1275
7. Bautista E, Chotpitayasunondh T, Gao Z., et al. Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med: 2010; 362 18 1708 1719
8. Kristoffersen KB, Sogaard OS, Wejse C., et al. Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admissiona randomized trial. Clin Microbiol Infect: 2009; 15 5 481 487
9. Burkhardt O, Ewig S, Haagen U., et al. Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection. Eur Respir J: 2010; 36 3 601 607
10. Johansson N, Kalin M, Tiveljung-Lindell A, Giske CG, Hedlund J. Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods. Clin Infect Dis: 2010; 50 2 202 209
11. Duchin JS, Koster FT, Peters CJ., et al. The Hantavirus Study Group Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. N Engl J Med: 1994; 330 14 949 955 (Pubitemid 24103592)
12. van den Hoogen BG, de Jong JC, Groen J., et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med: 2001; 7 6 719 724 (Pubitemid 32588029)
13. Murdoch DR, Chambers ST. Atypical pneumoniatime to breathe new life into a useful term? Lancet Infect Dis: 2009; 9 8 512 519
14. Lorber B, Fekete T. Community-acquired pneumonia. The tyranny of a term. The Pharos: 2011; Spring 19 21
15. Fang GD, Fine M, Orloff J., et al. New and emerging therapies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore): 1990; 69 5 307 310
16. Fraser DW, Tsai TR, Orenstein W., et al. Legionnaires' disease: description of an epidemic of pneumonia. N Engl J Med: 1977; 297 22 1189 1197 (Pubitemid 8226679)
17. Tsai TF, Finn DR, Plikaytis BD, McCauley W, Martin SM, Fraser DW. Legionnaires' disease: clinical features of the epidemic in Philadelphia. Ann Intern Med: 1979; 90 4 509 517 (Pubitemid 9167965)
18. McDade JE, Shepard CC, Fraser DW, Tsai TR, Redus MA, Dowdle WR., and the Laboratory Investigation Team. Legionnaires' disease: isolation of a bacterium and demonstration of its role in other respiratory disease. N Engl J Med: 1977; 297 22 1197 1203 (Pubitemid 8226680)
19. Luck PC. Diagnostics and clinical disease treatment. In: Heuner K, Swanson M. eds. LegionellaMolecular Microbiology. Norfolk, UK Caister Academic Press: 2008; 19 34
20. Marrie TJ, Garay JR, Weir E. Legionellosis: Why should I test and report? CMAJ: 2010; 182 14 1538 1542
21. Thomas DL, Mundy LM, Tucker PC. Hot tub legionellosis: Legionnaires' disease and Pontiac fever after a point-source exposure to Legionella pneumophila. Arch Intern Med: 1993; 153 22 2597 2599 (Pubitemid 23346189)
22. García-Fulgueiras A, Navarro C, Fenoll D., et al. Legionnaires' disease outbreak in Murcia, Spain. Emerg Infect Dis: 2003; 9 8 915 921 (Pubitemid 36944509)
23. Joseph CA.; European Working Group for Legionella Infections. Legionnaires' disease in Europe 2000-2002. Epidemiol Infect: 2004; 132 3 417 424 (Pubitemid 38714117)
24. Neil K, Berkelman R. Increasing incidence of legionellosis in the United States, 1990-2005: changing epidemiologic trends. Clin Infect Dis: 2008; 47 5 591 599
25. Hicks LA, Rose CE Jr, Fields BS., et al. Increased rainfall is associated with increased risk for legionellosis. Epidemiol Infect: 2007; 135 5 811 817 (Pubitemid 47161665)
26. Woodhead MA, Macfarlane JT. Legionnaires' disease: a review of 79 community acquired cases in Nottingham. Thorax: 1986; 41 8 635 640 (Pubitemid 16039656)
27. Yu VL, Kroboth FJ, Shonnard J, Brown A, McDearman S, Magnussen M. Legionnaires' disease: new clinical perspective from a prospective pneumonia study. Am J Med: 1982; 73 3 357 361 (Pubitemid 12031786)
28. Yu VL, Stout JE. Rapid diagnostic testing for community-acquired pneumonia: can innovative technology for clinical microbiology be exploited? Chest: 2009; 136 6 1618 1621
29. Shimada T, Noguchi Y, Jackson JL., et al. Systematic review and metaanalysis: urinary antigen tests for Legionellosis. Chest: 2009; 136 6 1576 1585
30. Waterer GW, Baselski VS, Wunderink RG. Legionella and community-acquired pneumonia: a review of current diagnostic tests from a clinician's viewpoint. Am J Med: 2001; 110 1 41 48 (Pubitemid 32056326)
31. Zhou G, Cao B, Dou Y, Liu Y, Feng L, Wang L. PCR methods for the rapid detection and identification of four pathogenic Legionella spp. and two Legionella pneumophila subspecies based on the gene amplification of gyrB. Appl Microbiol Biotechnol: 2011; 91 3 777 787
32. Blázquez Garrido RM, Espinosa Parra FJ, Alemany Francés L., et al. Antimicrobial chemotherapy for Legionnaires disease: levofloxacin versus macrolides. Clin Infect Dis: 2005; 40 6 800 806
33. Plouffe JF, Breiman RF, Fields BS., et al. Azithromycin in the treatment of Legionella pneumonia requiring hospitalization. Clin Infect Dis: 2003; 37 11 1475 1480 (Pubitemid 37494675)
34. Stout JE, Yu VL. Legionellosis. N Engl J Med: 1997; 337 10 682 687
35. Tubach F, Ravaud P, Salmon-Céron D., et al. Recherce Axée sur la Tolérance des Biothérapies Group Emergence of Legionella pneumophila pneumonia in patients receiving tumor necrosis factor-alpha antagonists. Clin Infect Dis: 2006; 43 10 e95 e100
36. Whiley H, Bentham R. Legionella longbeachae and legionellosis. Emerg Infect Dis: 2011; 17 4 579 583
37. Muder R. Other Legionella species. In: Mandell GL, Bennett JE, Dolin R. eds. Mandell, Douglas and Bennet's Principles and Practice of Infectious Diseases. 7th ed. Philadelphia, PA Churchill, Livingstone, Elsevier: 2010; 2985 2989
38. Yu VL, Plouffe JF, Pastoris MC., et al. Distribution of Legionella species and serogroups isolated by culture in patients with sporadic community-acquired legionellosis: an international collaborative survey. J Infect Dis: 2002; 186 1 127 128 (Pubitemid 34666926)
39. Phares CR, Russell E, Thigpen MC., et al. Legionnaires' disease among residents of a long-term care facility: the sentinel event in a community outbreak. Am J Infect Control: 2007; 35 5 319 323 (Pubitemid 46907324)
40. Mitchell CM, Hovis KM, Bavoil PM, Myers GSA, Carrasco JA, Timms P. Comparison of koala LPCoLN and human strains of Chlamydia pneumoniae highlights extended genetic diversity in the species. BMC Genomics: 2010; 11 442
41. Grayston JT, Kuo CC, Wang SP, Altman J. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med: 1986; 315 3 161 168 (Pubitemid 16097964)
42. Burillo A, Bouza E. Chlamydophila pneumoniae. Infect Dis Clin North Am: 2010; 24 1 61 71
43. Gaydos CA, Fowler CL, Gill VJ, Eiden JJ, Quinn TC. Detection of Chlamydia pneumoniae by polymerase chain reaction-enzyme immunoassay in an immunocompromised population. Clin Infect Dis: 1993; 17 4 718 723 (Pubitemid 23293385)
44. Marrie TJ, Peeling RW, Reid T, De Carolis E.; Canadian Community-Acquired Pneumonia Investigators Chlamydia species as a cause of community-acquired pneumonia in Canada. Eur Respir J: 2003; 21 5 779 784 (Pubitemid 36592284)
45. Megran D, Marrie TJ, Marrie TJ. Chlamydia pneumoniae pneumonia, an evolving clinical spectrum. Can J Infect Dis Med Microbiol: 1995; 6 191 195
46. Nakashima K, Tanaka T, Kramer MH., et al. Outbreak of Chlamydia pneumoniae infection in a Japanese nursing home, 1999-2000. Infect Control Hosp Epidemiol: 2006; 27 11 1171 1177 (Pubitemid 44807459)
47. Ewig S, Torres A. Is Chlamydia pneumoniae an important pathogen in patients with community-acquired pneumonia? Eur Respir J: 2003; 21 5 741 742 (Pubitemid 36592277)
48. Harris RL, Williams TW Jr. "Contribution to the Question of Pneumotyphuso": a discussion of the original article by J. Ritter in 1880. Rev Infect Dis: 1985; 7 1 119 122
49. Yung AP, Grayson ML. Psittacosisa review of 135 cases. Med J Aust: 1988; 148 5 228 233
50. Cunha CB. The first atypical pneumonia: the history of the discovery of Mycoplasma pneumoniae. Infect Dis Clin North Am: 2010; 24 1 1 5
51. Chanock RM. Mycoplasma infections of man. N Engl J Med: 1965; 273 22 1199 1206, 1257-1264
52. Herrmann R, Reiner B. Mycoplasma pneumoniae and Mycoplasma genitalium: a comparison of two closely related bacterial species. Curr Opin Microbiol: 1998; 1 5 572 579 (Pubitemid 128433645)
53. Catrein I, Herrmann R. The proteome of Mycoplasma pneumoniae, a supposedly "simpleo" cell. Proteomics: 2011; 11 18 3614 3632
54. Marston BJ, Plouffe JF, File TM Jr., et al. The Community-Based Pneumonia Incidence Study Group Incidence of community-acquired pneumonia requiring hospitalization: results of a population-based active surveillance Study in Ohio. Arch Intern Med: 1997; 157 15 1709 1718 (Pubitemid 27327407)
55. Marrie TJ. Mycoplasma pneumoniae pneumonia requiring hospitalization, with emphasis on infection in the elderly. Arch Intern Med: 1993; 153 4 488 494 (Pubitemid 23064992)
56. Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev: 2008; 32 6 956 973
57. Narita M. Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia. J Infect Chemother: 2010; 16 3 162 169
58. Khan FY., A yassin M. Mycoplasma pneumoniae associated with severe autoimmune hemolytic anemia: case report and literature review. Braz J Infect Dis: 2009; 13 1 77 79
59. Landsteiner K. Über beziehungen zwischen dem blutserum und den korperzeller. Munch Med Wochenschr: 1903; 50 1812
60. Schubothe H. The cold hemagglutinin disease. Semin Hematol: 1966; 3 1 27 47
61. Clough MC, Richter IM. A study of an autoagglutinin occurring in a human serum. Johns Hopkins Hosp Bull: 1918; 29 86
62. Peterson OL, Ham TH, Finland M. Cold agglutinins (autohemagglutinins) in primary atypical pneumonia. Science: 1943; 97 2511 167
63. Turner JC. Development of cold agglutinins in atypical pneumonia. Nature: 1943; 151 3832 419 420
64. Turner JC, Jackson EB, Nisnewitz S, Berney R. Relation of cold agglutinins to atypical pneumonia. Lancet: 1943; 1 765 769
65. Shone S, Passmore R. Pneumonitis associated with autohemagglutination: 1943; 242 6267 445 446
66. Helwig FC, Freis ED. Cold autohemagglutinins following atypical pneumonia producing the clinical picture of acrocyanosis. JAMA: 1943; 123 626
67. Horstmann DM, Tatlock H. Cold agglutinins: a diagnostic aid in certain types of primary atypical pneumonia. JAMA: 1943; 122 369
68. Favour CB. Autohemagglutinins -o"cold agglutinins. J Clin Invest: 1944; 23 6 891 897
69. Eaton MD, van Herick W, Meiklejohn GJ. Studies on the etiology of primary atypical pneumonia. III Specific neutralization of the virus by human serum. Exp Med: 1945; 82 329
70. Meiklejohn G, Eaton MD, van Herick WJ. A clinical report on cases of primary atypical pneumonia caused by a new virus. Clin Investig: 1945; 24 241 250
71. Cunha CB. The first atypical pneumonia: the history of the discovery of Mycoplasma pneumoniae. Infect Dis Clin North Am: 2010; 24 1 1 5
72. Cook MK, Chanock RM, Fox HH, Huebner RJ, Buescher EL, Johnson RT. Role of Eaton agent in disease of lower respiratory tract: evidence for infection in adults. BMJ: 1960; 1 5177 905 911
73. Mufson MA, Manko MA, Kingston JR, Chanock RM. Eaton agent pneumonia clinical features. JAMA: 1961; 178 369 374
74. Jansson E, Wager O. Cold agglutinins in pneumonia. Acta Med Scand: 1964; 175 747 750
75. Barile MF. Mycoplasma-tissue cell interactions. In: Tully JG, Whitcomb RF. eds. The Mycoplasmas II. Human and Animal Mycoplasmas. Vol 2. New York, NY Academic: 1979; 425 474
76. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev: 2004; 17 4 697 728 (Pubitemid 39372513)
77. Xu F, Dai C-L, Wu X-M, Chu P. Overwhelming postsplenectomy infection due to Mycoplasma pneumoniae in an asplenic cirrhotic patient: case report. BMC Infect Dis: 2011; 11 162
78. Miyashita N, Maruyama T, Kobayashi T., et al. Community-acquired macrolide-resistant Mycoplasma pneumoniae pneumonia in patients more than 18 years of age. J Infect Chemother: 2011; 17 1 114 118
79. Narita M. Two unexpected phenomena in macrolide-resistant Mycoplasma pneumoniae infection in Japan and the unique biological characteristics of Mycoplasma pneumoniae. J Infect Chemother: 2011; 17 5 735 736
80. Smith LG. Mycoplasma pneumonia and its complications. Infect Dis Clin North Am: 2010; 24 1 57 60
81. Marcos MA, Esperatti M, Torres A. Viral pneumonia. Curr Opin Infect Dis: 2009; 22 2 143 147
82. Caliendo AM. Multiplex PCR and emerging technologies for the detection of respiratory pathogens. Clin Infect Dis: 2011; 52 04 S326 S330
83. Johansson N, Kalin M, Hedlund J. Clinical impact of combined viral and bacterial infection in patients with community-acquired pneumonia. Scand J Infect Dis: 2011; 43 8 609 615
84. Blount RE Jr, Morris JA, Savage RE. Recovery of cytopathogenic agent from chimpanzees with coryza. Proc Soc Exp Biol Med: 1956; 92 3 544 549
85. Chanock R, Roizman B, Myers R. Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA), I: Isolation, properties and characterization. Am J Hyg: 1957; 66 3 281 290
86. Thompson WW, Shay DK, Weintraub E., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA: 2003; 289 2 179 186 (Pubitemid 36068705)
87. Walsh EE, Peterson DR, Falsey AR. Is clinical recognition of respiratory syncytial virus infection in hospitalized elderly and high-risk adults possible? J Infect Dis: 2007; 195 7 1046 1051 (Pubitemid 46452111)
88. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med: 2005; 352 17 1749 1759 (Pubitemid 40570923)
89. Caram LB, Chen J, Taggart EW., et al. Respiratory syncytial virus outbreak in a long-term care facility detected using reverse transcriptase polymerase chain reaction: an argument for real-time detection methods. J Am Geriatr Soc: 2009; 57 3 482 485
90. Rosen L. A hemagglutination-inhibition technique for typing adenoviruses. Am J Hyg: 1960; 71 120 128
91. Gray GC, Chorazy ML. Human adenovirus 14a: a new epidemic threat. J Infect Dis: 2009; 199 10 1413 1415
92. Lewis PF, Schmidt MA, Lu X., et al. A community-based outbreak of severe respiratory illness caused by human adenovirus serotype 14. J Infect Dis: 2009; 199 10 1427 1434
93. Esposito DH, Gardner TJ, Schneider E., et al. Outbreak of pneumonia associated with emergent human adenovirus serotype 14Southeast Alaska, 2008. J Infect Dis: 2010; 202 2 214 222
94. Hakim FA, Tleyjeh IM. Severe adenovirus pneumonia in immunocompetent adults: a case report and review of the literature. Eur J Clin Microbiol Infect Dis: 2008; 27 2 153 158
95. van den Hoogen BG, de Jong JC, Groen J., et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med: 2001; 7 6 719 724 (Pubitemid 32588029)
96. Crowe JE Jr. Human metapneumovirus as a major cause of human respiratory tract disease. Pediatr Infect Dis J: 2004; 23 11 Suppl S215 S221 (Pubitemid 44146416)
97. Johnstone J, Majumdar SR, Fox JD, Marrie TJ. Human metapneumovirus pneumonia in adults: results of a prospective study. Clin Infect Dis: 2008; 46 4 571 574 (Pubitemid 351263498)
98. Williams JV, Martino R, Rabella N., et al. A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections. J Infect Dis: 2005; 192 6 1061 1065 (Pubitemid 41266804)
99. Englund JA, Boeckh M, Kuypers J., et al. Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients. Ann Intern Med: 2006; 144 5 344 349 (Pubitemid 46768189)
100. Bautista E, Chotpitayasunondh T, Gao Z., et al. Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med: 2010; 362 18 1708 1719
101. Jhung MA, Swerdlow D, Olsen SJ., et al. Epidemiology of 2009 pandemic influenza A (H1N1) in the United States. Clin Infect Dis: 2011; 52 01 S13 S26
102. Louie JK, Acosta M, Jamieson DJ, Honein MA.; California Pandemic (H1N1) Working Group Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med: 2010; 362 1 27 35
103. Louie JK, Acosta M, Samuel MC., et al. California Pandemic (H1N1) Working Group A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1). Clin Infect Dis: 2011; 52 3 301 312
104. Lat A, Bhadelia N, Miko B, Furuya EY, Thompson GR III. Invasive aspergillosis after pandemic (H1N1) 2009. Emerg Infect Dis: 2010; 16 6 971 973
105. Zarychanski R, Stuart TL, Kumar A., et al. Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. CMAJ: 2010; 182 3 257 264
106. Lee N, Chan PKS, Hui DSC., et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis: 2009; 200 4 492 500
107. Lee N, Choi KW, Chan PK., et al. Outcomes of adults hospitalised with severe influenza. Thorax: 2010; 65 6 510 515
108. Lee N, Chan PKS, Lui GCY., et al. Complications and outcomes of pandemic 2009 Influenza A (H1N1) virus infection in hospitalized adults: how do they differ from those in seasonal influenza? J Infect Dis: 2011; 203 12 1739 1747
109. Godlee A, Almond MH, Dong T. Pathogenesis of influenza: virus-host interactions. Expert Rev Anti Infect Ther: 2011; 9 8 573 575
110. Dellinger RP, Carlet JM, Masur H., et al. Surviving Sepsis Campaign Management Guidelines Committee Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med: 2004; 32 3 858 873: e873corrected in Crit Care Med 2004;32:1448 (Pubitemid 38344143)
111. Petrucci N, Iacovelli W. Lung protective ventilation strategy for the acute respiratory distress syndrome. Cochrane Database Syst Rev: 2007; 18 3 CD003844
112. Meade MO, Cook DJ, Guyatt GH., et al. Lung Open Ventilation Study Investigators Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA: 2008; 299 6 637 645 (Pubitemid 351252725)
113. Peek GJ, Mugford M, Tiruvoipati R., et al. CESAR trial collaboration Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet: 2009; 374 9698 1351 1363
114. Peek GJ, Moore HM, Moore N, Sosnowski AW, Firmin RK. Extracorporeal membrane oxygenation for adult respiratory failure. Chest: 1997; 112 3 759 764 (Pubitemid 27410715)
115. Davies A, Jones D, Bailey M., et al. Australian and New Zealand Extracorporeal Membrane Oxygenation Influenza Investigators. Extracorporeal membrane oxygenation for 2009 influenza A (H1N1) acute respiratory distress syndrome. JAMA: 2009; 302 1885 1895
116. Conrad SA, Rycus PT, Dalton H. Extracorporeal life support registry report 2004. ASAIO J: 2005; 51 1 4 10 (Pubitemid 40165243)
117. do Carmo Debur M, Raboni SM, Flizikowski FBZ., et al. Immunohistochemical assessment of respiratory viruses in necropsy samples from lethal non-pandemic seasonal respiratory infections. J Clin Pathol: 2010; 63 10 930 934
118. Imakita M, Shiraki K, Yutani C, Ishibashi-Ueda H. Pneumonia caused by rhinovirus. Clin Infect Dis: 2000; 30 3 611 612 (Pubitemid 30205321)
119. Johnson JE, Gonzales RA, Olson SJ, Wright PF, Graham BS. The histopathology of fatal untreated human respiratory syncytial virus infection. Mod Pathol: 2007; 20 1 108 119 (Pubitemid 44967956)
120. Donoso AF, León JA, Camacho JF, Cruces PI, Ferrés M. Fatal hemorrhagic pneumonia caused by human metapneumovirus in an immunocompetent child. Pediatr Int: 2008; 50 4 589 591
121. Soto-Abraham MV, Soriano-Rosas J, Díaz-Quiñónez A., et al. Pathological changes associated with the 2009 H1N1 virus. N Engl J Med: 2009; 361 20 2001 2003
122. Mauad T, Hajjar LA, Callegari GD., et al. Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit Care Med: 2010; 181 1 72 79
123. Nicholls JM, Poon LLM, Lee KC., et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet: 2003; 361 9371 1773 1778 (Pubitemid 36638425)
124. Korteweg C, Gu J. Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans. Am J Pathol: 2008; 172 5 1155 1170 (Pubitemid 351671530)
125. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S., et al. INER Working Group on Influenza Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med: 2009; 361 7 680 689
126. Guarner J, Falcón-Escobedo R. Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses. Arch Med Res: 2009; 40 8 655 661
127. Stocker JT, Conran RM, Fishback N. Respiratory syncytial virus. In: Connor DH, Chandler FW, Mans HJ., et al., eds. Pathology of Infectious Diseases. Stamford, CT Appleton & Lange: 1997; 287 295
128. Winn WC, Walker DH. Viral infections. In: Dail DH, Hammar SP. eds. Pulmonary Pathology. 2nd ed. New York Springer-Verlag: 1994; 429 464
129. King JC Jr, Burke AR, Clemens JD., et al. Respiratory syncytial virus illnesses in human immunodeficiency virus- and noninfected children. Pediatr Infect Dis J: 1993; 12 9 733 739 (Pubitemid 23269331)
130. Vargas SO, Kozakewich HPW, Perez-Atayde AR, McAdam AJ. Pathology of human metapneumovirus infection: insights into the pathogenesis of a newly identified respiratory virus. Pediatr Dev Pathol: 2004; 7 5 478 486, discussion 421 (Pubitemid 40385238)
131. Sumino KC, Agapov E, Pierce RA., et al. Detection of severe human metapneumovirus infection by real-time polymerase chain reaction and histopathological assessment. J Infect Dis: 2005; 192 6 1052 1060 (Pubitemid 41266803)
132. Rowbotham TJ. Preliminary report on the pathogenicity of Legionella pneumophila for freshwater and soil amoebae. J Clin Pathol: 1980; 33 12 1179 1183 (Pubitemid 11160649)
133. Raoult D, Audic S, Robert C., et al. The 1.2-megabase genome sequence of Mimivirus. Science: 2004; 306 5700 1344 1350 (Pubitemid 39532506)
134. Legendre M, Santini S, Rico A, Abergel C, Claverie JM. Breaking the 1000-gene barrier for Mimivirus using ultra-deep genome and transcriptome sequencing. Virol J: 2011; 8 99
135. Ghigo E, Kartenbeck J, Lien P., et al. Amoebal pathogen mimivirus infects macrophages through phagocytosis. PLoS Pathog: 2008; 4 6 e1000087
136. Khan M, La Scola B, Lepidi H, Raoult D. Pneumonia in mice inoculated experimentally with Acanthamoeba polyphaga mimivirus. Microb Pathog: 2007; 42 2-3 56 61
137. Marrie TJ, Raoult D, La Scola B, Birtles RJ, de Carolis E.; Canadian Community-Acquired Pneumonia Study Group Legionella-like and other amoebal pathogens as agents of community-acquired pneumonia. Emerg Infect Dis: 2001; 7 6 1026 1029 (Pubitemid 33115786)
138. Greub G, Raoult D. Microorganisms resistant to free-living amoebae. Clin Microbiol Rev: 2004; 17 2 413 433 (Pubitemid 38534035)
139. La Scola B, Marrie TJ, Auffray JP, Raoult D. Mimivirus in pneumonia patients. Emerg Infect Dis: 2005; 11 3 449 452 (Pubitemid 40315733)
140. Berger P, Papazian L, Drancourt M, La Scola B, Auffray JP, Raoult D. Ameba-associated microorganisms and diagnosis of nosocomial pneumonia. Emerg Infect Dis: 2006; 12 2 248 255
141. Vincent A, La Scola B, Forel JM, Pauly V, Raoult D, Papazian L. Clinical significance of a positive serology for mimivirus in patients presenting a suspicion of ventilator-associated pneumonia. Crit Care Med: 2009; 37 1 111 118
142. Raoult D, Renesto P, Brouqui P. Laboratory infection of a technician by mimivirus. Ann Intern Med: 2006; 144 9 702 703
143. Larcher C, Jeller V, Fischer H, Huemer HP. Prevalence of respiratory viruses, including newly identified viruses, in hospitalised children in Austria. Eur J Clin Microbiol Infect Dis: 2006; 25 11 681 686 (Pubitemid 44806775)
144. La Scola B, Campocasso A, N'Dong R., et al. Tentative characterization of new environmental giant viruses by MALDI-TOF mass spectrometry. Intervirology: 2010; 53 5 344 353
145. La Scola B, Boyadjiev I, Greub G, Khamis A, Martin C, Raoult D. Amoeba-resisting bacteria and ventilator-associated pneumonia. Emerg Infect Dis: 2003; 9 7 815 821 (Pubitemid 36801581)
146. Harris JK, De Groote MA, Sagel SD., et al. Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc Natl Acad Sci U S A: 2007; 104 51 20529 20533
147. Cohen G, Hoffart L, La Scola B, Raoult D, Drancourt M. Ameba-associated Keratitis, France. Emerg Infect Dis: 2011; 17 7 1306 1308